GRP and breast carcinoma: The in vitro studies performed on the T47D breast cancer cell line, rich in both GRPR and folate receptor (FR), clearly showed specificity of the conjugates towards the receptors and presented better cellular uptake for the dendrimeric system as compared to free [177Lu]Lu-folate-bombesin, highlighting the beneficial effect of the carrier.